SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Rakovina Therapeutics to Present ATR Inhibitor Data at EORTC-NCI-AACR Symposium

Rakovina Therapeutics says it will present ATR inhibitor data in PTEN-deficient prostate cancer at the 38th EORTC-NCI-AACR Symposium.

RKVTF

Related stories